Compare · CDXS vs LIN
CDXS vs LIN
Side-by-side comparison of Codexis Inc. (CDXS) and Linde plc (LIN): market cap, price performance, sector, and recent activity on the wire.
Summary
- CDXS operates in Industrials, while LIN operates in Basic Materials - the two are in different parts of the market.
- LIN is the larger of the two at $161.42B, about 792.8x CDXS ($203.6M).
- LIN has hit the wire 3 times in the past 4 weeks while CDXS has been quiet.
- LIN has more recent analyst coverage (25 ratings vs 12 for CDXS).
- Company
- Codexis Inc.
- Linde plc
- Price
- -
- -
- Market cap
- $203.6M
- $161.42B
- 1M return
- -
- -
- 1Y return
- -
- -
- Industry
- Major Chemicals
- Major Chemicals
- Exchange
- NASDAQ
- NYSE
- IPO
- 2010
- News (4w)
- 0
- 3
- Recent ratings
- 12
- 25
Codexis Inc.
Codexis, Inc. discovers, develops, and sells biocatalysts. It offers intermediate chemicals products that are used for further chemical processing; and Codex biocatalyst panels and kits that enable customers to perform chemistry screening. The company also provides biocatalyst screening and protein engineering services. In addition, it offers CodeEvolver protein engineering technology platform, which helps in developing and delivering biocatalysts that perform chemical transformations. The company's platform is used to discover novel biotherapeutic drug candidates for targeted human diseases, as well as for molecular biology and in vitro diagnostic enzymes. Its platform also enhances the pharmaceuticals companies manufacturing productivity and efficiency or outsourcing the manufacture of the intermediates and active pharmaceutical ingredients. The company sells its products to pharmaceutical manufacturers through its direct sales and business development force in the United States and Europe. Codexis, Inc. was founded in 2002 and is headquartered in Redwood City, California.
Linde plc
Linde plc operates as an industrial gas company in North and South America, Europe, the Middle East, Africa, and the Asia Pacific. It offers oxygen, nitrogen, argon, rare gases, carbon dioxide, hydrogen, helium, electronic and specialty gases, acetylene, and carbon monoxide. The company also designs and constructs turnkey process plants, such as olefin, natural gas, air separation, hydrogen and synthesis gas, and other plants. It serves healthcare, petroleum refining, manufacturing, food, beverage carbonation, fiber-optics, steel making, aerospace, electronics, chemical, and water treatment industries. The company was founded in 1879 and is based in Guildford, the United Kingdom.
Latest CDXS
- SEC Form 8-K filed by Codexis Inc.
- SEC Form 4 filed by Director Parker H Stewart
- SEC Form 4 filed by Director Collins Cynthia
- SEC Form 4 filed by Director Richards Christos
- SEC Form 4 filed by Director Smith David V
- SEC Form 4 filed by Director Singhvi Rahul
- SEC Form 4 filed by Director Martinborough Esther
- SEC Form 4 filed by Director Dilly Stephen George
- SEC Form 4 filed by Director De Vre Raymond
- Director De Vre Raymond sold $6,174 worth of shares (2,605 units at $2.37), decreasing direct ownership by 3% to 84,811 units (SEC Form 4)
Latest LIN
- SEC Form 4 filed by Director Grant Hugh
- SEC Form 4 filed by Director Reynolds Paula Rosput
- Linde Announces Second Quarter 2026 Earnings and Conference Call Schedule
- SEC Form PX14A6G filed by Linde plc
- SEC Form 11-K filed by Linde plc
- SEC Form 11-K filed by Linde plc
- SVP, Linde Engineering Innocenzi Stefanos converted options into 4,035 units of Ordinary Shares and covered exercise/tax liability with 2,062 units of Ordinary Shares (SEC Form 4) to satisfy tax liability
- Linde Publishes 2025 Sustainable Development Report
- SEC Form SD filed by Linde plc
- New insider Brown Denny claimed ownership of 3,467 units of Ordinary Shares (SEC Form 3)